ERN CRANIO

What ERN CRANIO does

ERN CRANIO is the European Reference Network for rare and/or complex craniofacial anomalies and ear, nose and throat (ENT) disorders, officially launched in March 2017 as one of 24 European Reference Networks funded by the European Union. The network connects 36 expert member hospitals across 15 EU/EEA countries, coordinating multidisciplinary healthcare professionals including craniofacial surgeons, ENT specialists, geneticists, and nurses. It is coordinated from Erasmus Medical Center in Rotterdam, Netherlands, under the leadership of Coordinator Prof. dr. Irene Mathijssen and project managers Inga Bos, Ikram L'khssim, and Kristin Billaud Feragen.

The network's core technology is the CPMS 2.0 (Clinical Patient Management System), a digital platform now available on iOS, Android, and desktop (version 4.2) that enables secure, cross-border virtual multidisciplinary case discussions. Beyond the platform, ERN CRANIO develops and endorses European clinical practice guidelines for conditions including craniosynostosis, craniofacial microsomia, cleft lip/palate, Robin sequence, neurofibromatosis, and facial dysostosis, with patient-tailored versions produced in collaboration with patient representatives. It also produces multi-language animation videos on conditions and surgical techniques, runs hands-on training workshops such as the CF Necker Workshop, and provides transition-of-care resources from pediatric to adult services. Patient representatives (ePAGs) are integrated into governance alongside EURORDIS, and the network maintains cross-ERN partnerships with ERNICA, ERN eUROGEN, and the European Society of Human Genetics.

ERN CRANIO does not operate as a commercial enterprise and charges no fees for participation or services. Its funding comes from the European Commission via the Health and Digital Executive Agency (HaDEA) under the EU Health Programme, and it is part of an EU-wide infrastructure connecting over 1,600 expert centres across 375 hospitals. Distribution is via the member hospital network and the CPMS digital platform, targeting both healthcare providers (clinical collaboration, guidelines, training) and patients/families (education resources, care pathway navigation). Its two primary customer segments are specialist healthcare providers and the rare-disease patient community across Europe.

Name

ERN CRANIO

Legal name

ERN CRANIO (European Reference Network for rare and/or complex craniofacial anomalies and ear, nose and throat (ENT) disorders)

Website

https://ern-cranio.eu

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

101–250 employees

Short description

ERN CRANIO is a European Union-funded reference network that connects 36 expert hospitals across 15 EU/EEA countries to coordinate multidisciplinary care, clinical guidelines, and cross-border case discussions for patients with rare craniofacial anomalies and ENT disorders.

Ownership category

akta.pro rank

Product category

Specialized Healthcare Network Coordination

NAICS

All Other Support Services (561990), All Other Business Support Services (561499)

SIC

Services-Misc Health & Allied Services, Nec (8090), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI)

akta.pro secondary industry

Healthcare Provider ERP (Hospital Operations, Supply Chain, Finance) (HDAEAEAH)

Keywords

• Rare disease networks
• Craniofacial care coordination
• Cross-border healthcare
• Clinical guidelines development
• Multidisciplinary case discussions

Headquarters

HQ city

Rotterdam

HQ country

Netherlands

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Distribution channels3 records

Marketing channels7 records

Core offering

ERN CRANIO is the European Reference Network for rare and complex craniofacial anomalies, cleft lip/palate, orodental anomalies, and ENT disorders. It connects 36 member hospitals across 15 EU/EEA countries, enabling virtual multidisciplinary case discussions, co-developing European clinical practice guidelines, providing patient education resources, and running training workshops for clinicians. Services are delivered free of charge to member healthcare providers and patients, coordinated through the CPMS 2.0 digital platform.

Product overview

ERN CRANIO is the European Reference Network for rare and/or complex craniofacial anomalies and ENT disorders, operating as a coordination network rather than a commercial product company. The network provides clinical guidelines, patient education materials, and facilitates cross-border healthcare collaboration through the CPMS 2.0 platform. Key offerings include endorsed European clinical practice guidelines (craniosynostosis, craniofacial microsomia, cleft lip/palate, Robin sequence, neurofibromatosis, facial dysostosis), patient-tailored guideline versions, informative animation videos, educational workshops (CF Necker Workshop, Monobloc), and transition of care resources. The network connects 35 member hospitals across 15 EU/EEA countries.

Differentiator

Problem solved

Functional benefit

Products and services

• CPMS 2.0 (Clinical Patient Management System) Secure digital platform used by ERN members for cross-border virtual multidisciplinary team case discussions, available as desktop application (version 4.2) and as mobile apps on iOS and Android, designed for healthcare professionals across the 36 member hospitals.
• Clinical Guidelines and Standards of Care
• Patient Education Materials and Videos
• Transition of Care Resources
• Craniofacial Surgery Workshops and Training Hands-on educational workshops for craniofacial surgeons, including the CF Necker Workshop (e.g., unicoronal craniosynostosis and hypertelorism) and Monobloc workshops, with international expert faculty.

Quantifiable outcome

• 97% of workshop participants reported satisfaction with learning expectations met
• +1 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Nine partnerships are on record, tiered major, core and minor.

• Declaration on the European Innovation and Care Ecosystem for Rare and Complex DiseasesmajorStrategic or Co-development Partner · 25 February 2026ERN CRANIO participated in launching a declaration at the High-Level Meeting for Rare and Complex Diseases in December 2025, developed together with patients, clinicians, ERNs, researchers and industry partners. The declaration highlights 8 key actions for better rare disease care in Europe including faster diagnostics, improved treatment access, stronger research infrastructure, and dedicated EU funding for ERNs.
• European Commission / Health and Digital Executive Agency (HaDEA)coreStrategic or Co-development Partner · 1 March 2017ERN CRANIO is officially funded by the European Union, with the European Commission and HaDEA providing oversight, coordination, and funding. The network was officially launched in March 2017 as part of the EU's ERN initiative.
• EURORDIS / European Patient Advocacy Groups (ePAGs)coreStrategic or Co-development PartnerERN CRANIO collaborates with EURORDIS and its European Patient Advocacy Groups to ensure the patient voice is integrated throughout network development. Patient representatives participate in governance and help shape projects that make meaningful differences for patient communities.
• ERNICA (European Reference Network for Inherited and Congenital Anomalies)majorStrategic or Co-development PartnerCross-ERN collaboration between ERN CRANIO and ERNICA, particularly for OR nurses meetings and clinical exchanges. The networks share knowledge and best practices related to craniofacial and inherited anomalies.
• ERN eUROGENmajorStrategic or Co-development PartnerCross-ERN partnership with ERN eUROGEN, participating jointly in OR nurses meetings and sharing expertise across specialized European Reference Networks.
• European Commission DG SANTEcoreStrategic or Co-development PartnerRegular coordination meetings between all 24 ERN Coordinators and the European Commission's DG SANTE team, addressing topics including best practices, monitoring, CPMS implementation, and ERN expansion. The 22nd meeting was held in Rome in May 2025.
• European Society of Human Genetics (ESHG)majorStrategic or Co-development PartnerERN CRANIO Genetics Working Group Lead Wanda Lattanzi presented at the ESHG conference, and three ERN CRANIO members were appointed as liaison members to ESHG, forging stronger connections between ERNs and the European genetics community.
• JARDIN Joint ActionminorStrategic or Co-development PartnerCollaboration with JARDIN Joint Action on patient stories and transition of care initiatives, featuring patient narratives like Ivana's Story for Rare Disease Day.
• French Reference Center for Craniosynostoses (CRANIOST)majorStrategic or Co-development PartnerCRANIOST organized the 3rd CF Necker Workshop in collaboration with an international expert committee and with ERN CRANIO support, hosted at Necker-Enfants Malades Hospital in Paris.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Others

• Cleft Palate Foundation / Smile Train: Smile Train is a global cleft-focused NGO providing surgical care, training, and patient support. Comparable as a cleft lip/palate stakeholder that addresses one of ERN CRANIO's core disease areas, but operates as a charity rather than a clinical reference network.

Direct peers

• ERN EYE (European Reference Network for Eye Diseases): European Reference Network for rare eye diseases, operating under identical EU governance, funding, and cross-border collaboration framework. Comparable in scope, structure, and member hospital network size to ERN CRANIO.
• ERNICA (European Reference Network for Inherited and Congenital Anomalies): One of the 24 European Reference Networks, focused on inherited and congenital anomalies. ERN CRANIO and ERNICA are existing cross-ERN collaboration partners and share the same EU funding/governance structure, member hospital model, and CPMS platform for cross-border case discussions.
• ERN RND (European Reference Network for Rare Neurological Diseases): European Reference Network for rare neurological diseases, sharing the same EU funding structure, member hospital model, CPMS collaboration platform, and DG SANTE oversight as ERN CRANIO. Directly comparable as a peer ERN in the same 24-network EU infrastructure.
• ERN EURACAN (European Reference Network for Rare Adult Cancers): European Reference Network for rare adult solid tumours, operating under the same EU Health Programme and ERN governance model. Directly comparable in structure, funding source, member hospital network, and use of CPMS for cross-border multidisciplinary case discussions.
• ERN eUROGEN (European Reference Network for Urogenital Diseases): Another of the 24 European Reference Networks, focused on rare urogenital diseases. ERN eUROGEN is a confirmed ERN CRANIO cross-ERN partner (joint OR nurses meetings, expertise sharing) and operates under identical EU Health Programme funding and CPMS-based collaboration model.

Broad incumbents

• EURORDIS (Rare Disease Europe): European umbrella organisation for rare disease patient associations, including 1,000+ patient organisations. A confirmed ERN CRANIO partner via ePAGs, EURORDIS operates at broader scale across all 24 ERNs and represents the patient advocacy ecosystem ERN CRANIO plugs into.
• Orphanet: European reference portal for rare diseases and orphan drugs, providing a comprehensive database of rare diseases, expert centres, and clinical guidelines. Operates as broader infrastructure that complements and overlaps with ERN CRANIO's expert centre directory and clinical guideline library.

Emerging players

• Children's Craniofacial Association (CCA): US-based patient advocacy organisation specifically for craniofacial conditions, focused on family support, education, and awareness. Comparable as a craniofacial-specific patient community but at smaller scale and regional focus versus ERN CRANIO's pan-European clinical expert network.

Regional players

• NORD (National Organization for Rare Disorders): US-based patient advocacy organisation for rare diseases, serving a comparable function to ERN CRANIO at a national level. Comparable in mission (rare disease coordination, patient advocacy, education) but operates in a different regulatory and funding environment in the US.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/cranio_ern
• YouTubeyoutube.com/channel/UCqJ3R7w9lg5I7GaHm3nMi0A
• LinkedInlinkedin.com/company/ern-cranio
• Instagraminstagram.com/erncranio/?hl=en

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ERN CRANIO